PEXIOVEQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Jan 2023)
What this means for you
This application is over — abandoned 23 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88243807
- Mark type
- Stylized text
- Filed
- 28 Dec 2018
- Published for opposition
- 22 Oct 2019
- Abandoned
- 23 Jan 2023
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
- Class 042 — Scientific and technological services: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
Owner
- SillaJen, Inc., Seoul, KR
- SillaJen, Inc., Busan, KR
Prosecution history
- 23 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2022 — SOU EXTENSION 5 GRANTED
- 14 Jun 2022 — SOU EXTENSION 5 FILED
- 23 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 07 Jun 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Jun 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2021 — SOU EXTENSION 4 GRANTED
- 09 Dec 2021 — SOU EXTENSION 4 FILED
- 09 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED